Frontiers in Medicine | Nuclear Medicine

Review

Published on 04 Jan 2023

Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [223Ra]RaCl2 and [224Ra]RaCl2

in Nuclear Medicine

Michael Lassmann
Uta Eberlein

Frontiers in Medicine

doi 10.3389/fmed.2022.1057373

6,880 views
5 citations

Mini Review

Published on 22 Dec 2022

Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer

in Nuclear Medicine

Joe M. O’Sullivan
Rana R. McKay
Kambiz Rahbar
Karim Fizazi
Daniel J. George
Bertrand Tombal
Anja Schmall
Per Sandström
Frank Verholen
Neal Shore

Frontiers in Medicine

doi 10.3389/fmed.2022.1070392

8,206 views
11 citations

Review

Published on 22 Dec 2022

Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?

in Nuclear Medicine

Roger M. Pallares
Rebecca J. Abergel

Frontiers in Medicine

doi 10.3389/fmed.2022.1020188

21,530 views
53 citations

Case Report

Published on 20 Dec 2022

Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on 18F-FDG-PET/CT

in Nuclear Medicine

Karim Amrane
Coline Le Meur
Philippe Thuillier
Pierre Alemany
Clémence Niel
David Renault
Ronan Abgral

Frontiers in Medicine

doi 10.3389/fmed.2022.1078560

3,315 views
10 citations

Review

Published on 16 Dec 2022

Targeted alpha therapy for glioblastoma

in Nuclear Medicine

Jolanta Kunikowska
Alfred Morgenstern
Kacper Pełka
Frank Bruchertseifer
Leszek Królicki

Frontiers in Medicine

doi 10.3389/fmed.2022.1085245

7,927 views
20 citations

Editorial

Published on 12 Dec 2022

Editorial: Small animal imaging: Technological and methodological advances to improve the translational power

in Nuclear Medicine

Monique R. Bernsen
Wendy McDougald
Laura Mezzanotte
Carmel M. Moran
Adriana Tavares
Louise van der Weerd

Frontiers in Medicine

doi 10.3389/fmed.2022.1099233

2,171 views
1 citation

Review

Published on 07 Dec 2022

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists

in Nuclear Medicine

Mengqi Shi
Vivianne Jakobsson
Lukas Greifenstein
Pek-Lan Khong
Xiaoyuan Chen
Richard P. Baum
Jingjing Zhang

Frontiers in Medicine

doi 10.3389/fmed.2022.1034315

19,918 views
54 citations

Review

Published on 06 Dec 2022

Prostate specific membrane antigen binding radiopharmaceuticals: Current data and new concepts

in Nuclear Medicine

Oliver Sartor
Ali Baghian

Frontiers in Medicine

doi 10.3389/fmed.2022.1060922

9,337 views
16 citations

Brief Research Report

Published on 02 Dec 2022

Exploratory analysis of radiomic as prognostic biomarkers in 18F-FDG PET/CT scan in uterine cervical cancer

in Nuclear Medicine

Nadja Rolim Gonçalves de Alencar
Marcos Antônio Dórea Machado
Felipe Alves Mourato
Mércia Liane de Oliveira
Thauan Fernandes Moraes
Luiz Alberto Reis Mattos Junior
Tien-Man Cabral Chang
Carla Rameri Alexandre Silva de Azevedo
Simone Cristina Soares Brandão

Frontiers in Medicine

doi 10.3389/fmed.2022.1046551

3,569 views
12 citations

Editorial

Published on 02 Dec 2022

Editorial: Case reports in PET imaging

in Nuclear Medicine

Silvia Taralli
Natale Quartuccio
Gaurav Malviya

Frontiers in Medicine

doi 10.3389/fmed.2022.1087583

2,451 views
1 citation

Brief Research Report

Published on 02 Dec 2022

Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson’s disease

in Nuclear Medicine

Cecilia Boccalini
Giulia Carli
Emilia Giovanna Vanoli
Antoniangela Cocco
Alberto Albanese
Valentina Garibotto
Daniela Perani

Frontiers in Medicine

doi 10.3389/fmed.2022.1073720

2,676 views
8 citations

Mini Review

Published on 30 Nov 2022

18F-FDG PET molecular imaging: A relevant tool to investigate chronic inflammatory rheumatisms in clinical practice?

in Nuclear Medicine

Marie Pean De Ponfilly – Sotier
Raphaële Seror
Gaetane Nocturne
Florent L. Besson

Frontiers in Medicine

doi 10.3389/fmed.2022.1070445

4,887 views
8 citations

Original Research

Published on 30 Nov 2022

Radiation exposure to nuclear medicine technologists performing a V/Q PET: Comparison with conventional V/Q scintigraphy, [18F]FDG PET and [68Ga]Ga DOTATOC PET procedures

in Nuclear Medicine

Frédérique Blanc-Béguin
Pascal Damien
Romain Floch
Kévin Kerleguer
Simon Hennebicq
Philippe Robin
Pierre-Yves Salaün
Pierre-Yves Le Roux

Frontiers in Medicine

doi 10.3389/fmed.2022.1051249

2,926 views
4 citations

Original Research

Published on 25 Nov 2022

A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity

in Nuclear Medicine

Mario Jreige
Nicolas Hall
Fabio Becce
Bérengère Aubry-Rozier
Elena Gonzalez Rodriguez
Niklaus Schaefer
John O. Prior
Marie Nicod Lalonde

Frontiers in Medicine

doi 10.3389/fmed.2022.1050854

3,429 views
10 citations

Original Research

Published on 24 Nov 2022

Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging

in Nuclear Medicine

Francisca Mulero
Marta Oteo
Guillermo Garaulet
Natalia Magro
Lluvia Rebollo
Guillermo Medrano
Clara Santiveri
Eduardo Romero
Ricela E. Sellek
Yago Margolles

Frontiers in Medicine

doi 10.3389/fmed.2022.1058455

4,752 views
9 citations

Case Report

Published on 24 Nov 2022

Different uptake patterns of 68Ga-FAPI in aseptic loosening and periprosthetic joint infection of hip arthroplasty: A case series and literature review

in Nuclear Medicine

Yiqun Wang
Ruimin Wang
Lei Geng
Qingxiao Li
Erpeng Qi
Yuanyuan Shi
Yanmei Wang
Qingyuan Zheng
Guoqiang Zhang
Jiying Chen

Frontiers in Medicine

doi 10.3389/fmed.2022.1014463

5,392 views
10 citations

Original Research

Published on 23 Nov 2022

Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma

in Nuclear Medicine

Anna Julie Kjøl Tornes
Vilde Yuli Stenberg
Roy Hartvig Larsen
Øyvind Sverre Bruland
Mona-Elisabeth Revheim
Asta Juzeniene

Frontiers in Medicine

doi 10.3389/fmed.2022.1058863

5,170 views
11 citations

Study Protocol

Published on 18 Nov 2022

AlphaBet: Combination of Radium-223 and [177Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol)

in Nuclear Medicine

Louise Kostos
James P. Buteau
Theresa Yeung
Juliana Di Iulio
Jing Xie
Anthony Cardin
Kwang Y. Chin
Brittany Emmerson
Katie L. Owen
Belinda S. Parker

Frontiers in Medicine

doi 10.3389/fmed.2022.1059122

13,243 views
46 citations

Original Research

Published on 16 Nov 2022

PET image enhancement using artificial intelligence for better characterization of epilepsy lesions

in Nuclear Medicine

Anthime Flaus
Tahya Deddah
Anthonin Reilhac
Nicolas De Leiris
Marc Janier
Ines Merida
Thomas Grenier
Colm J. McGinnity
Alexander Hammers
Carole Lartizien

Frontiers in Medicine

doi 10.3389/fmed.2022.1042706

5,139 views
14 citations

Brief Research Report

Published on 16 Nov 2022

Use of 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients affected by polymyalgia rheumatica and persistent increase of acute phase reactants

in Nuclear Medicine

Michele Colaci
Jessika Dichiara
Maria Letizia Aprile
Massimo Ippolito
Claudia Schinocca
Giuliana Guggino
Lorenzo Malatino

Frontiers in Medicine

doi 10.3389/fmed.2022.1042620

2,328 views
8 citations

Original Research

Published on 15 Nov 2022

Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model

in Nuclear Medicine

Axel Berg-Larsen
Anne Mobergslien
Ingrid Moen
Gebregziabher Petros
Alexander Kristian
Kristine Sponheim Gunvaldsen
Véronique Cruciani
Katrine Wickstroem
Roger Malerbakken Bjerke
Jenny Karlsson

Frontiers in Medicine

doi 10.3389/fmed.2022.1033303

4,668 views
8 citations

Review

Published on 15 Nov 2022

Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227

in Nuclear Medicine

Peter M. Anderson
Vivek Subbiah
Matteo M. Trucco

Frontiers in Medicine

doi 10.3389/fmed.2022.1030094

6,607 views
10 citations

Case Report

Published on 10 Nov 2022

Multimodality imaging evaluation of nasal sinus alveolar rhabdomyosarcoma: Two case reports

in Nuclear Medicine

Wenpeng Huang
Yongbai Zhang
Ge Gao
Liming Li
Qi Yang
Yongkang Qiu
Lei Kang

Frontiers in Medicine

doi 10.3389/fmed.2022.1047464

5,157 views
8 citations

Review

Published on 10 Nov 2022

Poly (ADP-ribose) polymerases as PET imaging targets for central nervous system diseases

in Nuclear Medicine

Jie Tong
Baosheng Chen
Peng Wen Tan
Stephen Kurpiewski
Zhengxin Cai

Frontiers in Medicine

doi 10.3389/fmed.2022.1062432

4,514 views
7 citations

466 articles

articles

Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [223Ra]RaCl2 and [224Ra]RaCl2

Real-world effectiveness, long-term safety and treatment pathway integration of radium-223 therapy in patients with metastatic castration-resistant prostate cancer

Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?

Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on 18F-FDG-PET/CT

Targeted alpha therapy for glioblastoma

Editorial: Small animal imaging: Technological and methodological advances to improve the translational power

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists

Prostate specific membrane antigen binding radiopharmaceuticals: Current data and new concepts

Exploratory analysis of radiomic as prognostic biomarkers in 18F-FDG PET/CT scan in uterine cervical cancer

Editorial: Case reports in PET imaging

Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson’s disease

18F-FDG PET molecular imaging: A relevant tool to investigate chronic inflammatory rheumatisms in clinical practice?

Radiation exposure to nuclear medicine technologists performing a V/Q PET: Comparison with conventional V/Q scintigraphy, [18F]FDG PET and [68Ga]Ga DOTATOC PET procedures

A novel approach for fibrous dysplasia assessment using combined planar and quantitative SPECT/CT analysis of Tc-99m-diphosphonate bone scan in correlation with biological bone turnover markers of disease activity

Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging

Different uptake patterns of 68Ga-FAPI in aseptic loosening and periprosthetic joint infection of hip arthroplasty: A case series and literature review

Targeted alpha therapy with the 224Ra/212Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma

AlphaBet: Combination of Radium-223 and [177Lu]Lu-PSMA-I&T in men with metastatic castration-resistant prostate cancer (clinical trial protocol)

PET image enhancement using artificial intelligence for better characterization of epilepsy lesions

Use of 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients affected by polymyalgia rheumatica and persistent increase of acute phase reactants

Tumor growth inhibition and immune system activation following treatment with thorium-227 conjugates and PD-1 check-point inhibition in the MC-38 murine model

Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227

Multimodality imaging evaluation of nasal sinus alveolar rhabdomyosarcoma: Two case reports

Poly (ADP-ribose) polymerases as PET imaging targets for central nervous system diseases